Evidence map›Paper›PMID 22129094›Full record

ArticleCancer science2012

Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis.

Junkichi Koinuma, Hirohiko Akiyama, Masahiro Fujita, Masao Hosokawa, Eiju Tsuchiya, Satoshi Kondo, Yusuke Nakamura, Yataro Daigo

Abstract read
In one paragraph

Article in Cancer science, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The mitosis-related geneAnnals of translational medicine · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. OIP5 Expression Sensitize Glioblastoma Cells to Lomustine Treatment.Journal of molecular neuroscience : MN · 2018
    Article
  18. Article
  19. Article
  20. Opa interacting protein 5 acts as an oncogene in bladder cancer.Journal of cancer research and clinical oncology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Junkichi KoinumaLaboratory of Molecular Medicine, Human Genome Center, University of Tokyo, Tokyo, Japan.
Hirohiko Akiyama
Masahiro Fujita
Masao Hosokawa
Eiju Tsuchiya
Satoshi Kondo
Yusuke Nakamura
Yataro Daigo

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To identify potential molecular targets for diagnosis, treatment and/or prevention of lung and esophageal carcinomas, we screened for genes that were overexpressed in tumors through gene expression analyses of 120 lung cancers and 19 esophageal squamous-cell carcinomas using a cDNA microarray consisting of 27,648 cDNA or expressed sequence tags. In this process, we identified a gene, Opa interacting protein 5 (OIP5), to be highly transactivated in the majority of lung and esophageal cancers. Immunohistochemical staining using 336 archived non-small cell lung cancers and 305 esophageal squamous-cell carcinomas specimens demonstrated that OIP5 expression was significantly associated with poor prognosis of lung and esophageal cancer patients (P = 0.0053 and 0.0168, respectively), and multivariate analysis confirmed its independent prognostic value for non-small cell lung cancers (P = 0.0112). Suppression of OIP5 expression with siRNA effectively suppressed the growth of cancer cells, whereas the exogenous expression of OIP5 enhanced the growth of cancer cells. In addition, OIP5 protein is likely to be stabilized through its interaction with Raf1. OIP5 is a promising target for developing new prognostic biomarkers and anti-cancer drugs.

Indexed as

AdultAgedAged, 80 and overBiomarkers, TumorBlotting, NorthernBlotting, WesternCarcinoma, Squamous CellCell Cycle ProteinsCell Line, TumorChromosomal Proteins, Non-HistoneEsophageal NeoplasmsFemaleGene Expression ProfilingGenome-Wide Association StudyHumansImmunohistochemistryBiomarkers, TumorCell Cycle ProteinsChromosomal Proteins, Non-HistoneOIP5 protein, humanRNA, Small Interfering

Identifiers

PMID22129094
PMCPMC7713625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.